4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-055052
Chief Financial Officer acquired 65,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Lucera Erick · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-12 | Grant or award : show line 1 in the form | +65,000 | 131,100 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-12 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +105,000 | 105,000 | D |
Loading xslF345X05/ownership.xml…